Net loss from continuing operations widened to $85.5 million in 2025, compared to $46.3 million in 2024. Total revenues increased by 40.3% to $1,924.3 million in 2025 from $1,371.1 million in 2024. Premiums earned, net, grew 41% to $1,891.7 million in 2025, primarily due to a 33% increase in average members. Net medical claims incurred rose 56% to $1,568.4 million in 2025, driven by membership growth and increased Part D cost sharing due to the Inflation Reduction Act. The Insurance Benefits Expense Ratio (BER) increased to 90.9% in 2025 from 81.2% in 2024, with the Normalized BER at 91.5% in 2025 compared to 84.2% in 2024. Medicare Advantage (MA) membership at period end was 113,803 at December 31, 2025, up from 82,664 at December 31, 2024. During the 2026 Annual Election Period, MA membership grew 53% year-over-year, reaching over 153,000 members, with more than 97% enrolled in PPO plans. The Star Rating for PPO MA plans decreased to 3.5 Stars for the 2026 rating year (affecting 2027 payment year), while the HMO MA plan rating increased to 4.0 Stars. Net cash used in operating activities from continuing operations was $66.9 million in 2025, a shift from $82.5 million provided in 2024. The company launched Counterpart Health, Inc. in Q2 2024, a Software-as-a-Service (SaaS) and Tech Enabled Services Solution to offer Clover Assistant technology to external payors and providers. The Board authorized a $20.0 million share repurchase program on May 6, 2024, which was exhausted in Q1 2025, with $18.3 million repurchased in 2025.